Selective estrogen receptor modulators bind to estrogen receptors in the cancer cells and block estrogen from helping cancer cells to grow. Tamoxifen (Soltamox®), raloxifene (Evista®), and toremifene (Fareston®) are SERMs used to treat estrogen receptor–positive breast cancer. All three hormonal therapy drugs are administered orally.
LIMITED TIME:
3X MATCH for Breast Cancer Awareness Month
Support research with a legacy gift. Sample, non-binding bequest language:
I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).
